Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects
- 1 June 2016
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 38 (6) , 1401-1416
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Treatment of cachexia: An overview of recent developmentsInternational Journal of Cardiology, 2015
- Pharmacokinetic Interaction between Maraviroc and Fosamprenavir-Ritonavir: an Open-Label, Fixed-Sequence Study in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2013
- Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trialThe Lancet Oncology, 2013
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trialJournal of Cachexia, Sarcopenia and Muscle, 2011
- Discovery of the Selective Androgen Receptor Modulator MK-0773 Using a Rational Development Strategy Based on Differential Transcriptional Requirements for Androgenic Anabolism Versus Reproductive PhysiologyJournal of Biological Chemistry, 2010
- The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young MenThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2010
- Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)Drug Discovery Today, 2007
- An Orally Active Selective Androgen Receptor Modulator Is Efficacious on Bone, Muscle, and Sex Function with Reduced Impact on ProstateEndocrinology, 2007
- Selective Androgen Receptor Modulator Treatment Improves Muscle Strength and Body Composition and Prevents Bone Loss in Orchidectomized RatsEndocrinology, 2005
- Waist Circumference and Testosterone Levels in Community Dwelling Men. The Tromsø StudyEuropean Journal of Epidemiology, 2004